Pharmacyte BiotechPMCB
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 23 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings, unchanged from Q2 2025. 6 opened new positions and 6 sold out. The largest holders were Geode Capital Management, LLC ($123K), Equitec Proprietary Markets, LLC ($80K) and Renaissance Technologies ($78K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $15K |
| Exits | 6 | $56K |
All 13F filers, Q2 2025 → Q3 2025: 48,659 shares bought and 192,089 shares sold, net −143,430 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Geode Capital Management, LLC | 0.00% | No change | 126,603 | $123K |
| Equitec Proprietary Markets, LLC | 0.49% | No change | 82,727 | $80K |
| Renaissance Technologies | 0.00% | Add +60.6% | 80,000 | $78K |
| Vanguard Group Inc. | 0.00% | Reduce -61.5% | 74,919 | $73K |
| Schonfeld Strategic Advisors LLC | 0.00% | No change | 26,200 | $25K |
| Northern Trust Corp. | 0.00% | No change | 19,208 | $19K |
| Citadel Advisors | 0.00% | New | 14,531 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +99.3% | 5,551 | $5K |
| UBS Group AG | 0.00% | Reduce -94.1% | 1,323 | $1K |
| Simplex Trading, LLC | 0.00% | New | 1,100 | $1K |
| Bank of America Corp. | 0.00% | Reduce -0.7% | 538 | $522 |
| Osaic Holdings, Inc. | 0.00% | Reduce -0.3% | 304 | $294 |
| Sachetta, LLC | 0.00% | No change | 14 | $14 |
| Morgan Stanley | 0.00% | Add +800.0% | 9 | $10 |
| Bfsg, LLC | 0.00% | No change | 5 | $5 |
| Financial Consulate, Inc. | 0.00% | New | 2 | $2 |
| NewEdge Advisors, LLC | 0.00% | No change | 2 | $2 |
| Citigroup Inc. | 0.00% | New | 1 | $1 |
| IFP Advisors, Inc | 0.00% | No change | 1 | $1 |
| BlackRock, Inc. | 0.00% | New | 1 | $1 |
| Accredited Wealth Management, LLC | 0.00% | New | 50 | $1 |
| Cwm, LLC | 0.00% | No change | 1 | $0 |
| Covestor Ltd | 0.00% | No change | 275 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.